3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
103
Lymphoma
68
Lymphoma, Large B-Cell, Diffuse
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Sarcoma
33
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Leukemia
23
Burkitt Lymphoma
22
Neoplasms
19
Lymphoma, Mantle-Cell
18
Triple Negative Breast Neoplasms
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, B-Cell
14
Lymphoma, Large-Cell, Anaplastic
12
Carcinoma, Hepatocellular
12
Breast Neoplasms, Male
11
Neuroblastoma
10
Recurrence
9
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Inflammatory Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
8
Osteosarcoma
7
Fallopian Tube Neoplasms
7
Urinary Bladder Neoplasms
6
Liposarcoma
6
Interventions
fludarabine phosphate
10
Whole-Body Irradiation
8
Peripheral Blood Stem Cell Transplantation
8
Cyclophosphamide
8
Busulfan
8
Mycophenolic Acid
7
Tacrolimus
6
Antilymphocyte Serum
6
Methotrexate
5
Cyclosporine
5
Melphalan
4
Etoposide
4
thymoglobulin
3
Sirolimus
3
Rituximab
3
Radiotherapy
3
Cord Blood Stem Cell Transplantation
3
fludarabine
2
Ondansetron
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Cyclosporins
2
Carmustine
2
Calcium Dobesilate
2
Aprepitant
2
rasburicase
1
etoposide phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pdgfra-Associated Chronic Eosinophilic Leukemia
×
Doxorubicin
×
Clear all
No trials found.